Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Haw Par's Enterprise Value is S$-1,009.9 Mil.
Haw Par's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$230.9 Mil. Therefore, Haw Par's EV-to-EBIT ratio for today is -4.37.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Haw Par's Enterprise Value is S$-1,009.9 Mil.
Haw Par's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was S$237.0 Mil. Therefore, Haw Par's EV-to-EBITDA ratio for today is -4.26.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Haw Par's Enterprise Value is S$-1,009.9 Mil.
Haw Par's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was S$232.1 Mil. Therefore, Haw Par's EV-to-Revenue ratio for today is -4.35.
Haw Par Enterprise Value Historical Data
The historical data trend for Haw Par's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Haw Par's Enterprise Value
For the Drug Manufacturers - General subindustry, Haw Par's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Haw Par's Enterprise Value falls into.
Haw Par Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Haw Par's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (SGX:H02) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Haw Par's current Enterprise Value is S$-1,009.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Haw Par's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$230.9 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Haw Par's current Enterprise Value is S$-1,009.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Haw Par's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was S$237.0 Mil.
Haw Par's current Enterprise Value is S$-1,009.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Haw Par's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was S$232.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par Enterprise Value Related Terms
Thank you for viewing the detailed overview of Haw Par's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:H02 has been successfully added to your 